Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NLRP3 inflammasome is a high-molecular-weight multiprotein complex located in the cytosol of various cells, most notably professional antigen-presenting cells like macrophages and dendritic cells (UniProt KB - Q96P20). It functions as a key sensor of the innate immune system, responding to a diverse range of stimuli including microbial motifs, endogenous danger signals such as ATP or uric acid crystals, and environmental irritants (PubMed: 24854589). The complex consists of the NLRP3 sensor, the ASC adapter protein, and the effector enzyme pro-caspase-1. Activation of the complex triggers the proteolytic cleavage of pro-caspase-1 into its active form, which then processes the precursors of interleukin-1β (IL-1β) and interleukin-18 (IL-18) into their mature, secreted forms, while also inducing a form of programmed cell death known as pyroptosis (PubMed: 31034466). Chronic or excessive activation of the NLRP3 inflammasome is a central driver in the pathogenesis of numerous inflammatory, metabolic, and neurodegenerative diseases (PubMed: 27950320). As a result, it is a highly sought-after therapeutic target, with various small molecules in clinical development aimed at inhibiting its activation to mitigate systemic and local inflammation (PubMed: 29305584).
Direct binding to the NLRP3 NACHT domain to inhibit its ATPase activity, thereby preventing the oligomerization of NLRP3 and the subsequent recruitment of ASC and pro-caspase-1, which blocks the maturation of pro-inflammatory cytokines.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NLR family pyrin domain containing 3 inflammasome complex (NLRP3 inflammasome) (NLRP3 inflammasome).